oralvinorelbine相关论文
Phase Ⅱ study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative m
Objective: Apatinib is an oral TKI targeting VEGFR-2. Single-agent apatinib treatment has been shown to produce an objec......